Under the collaboration, Abbott has installed the ARCHITECT ci4100 analyser, one of its Core Laboratory platforms, in AUTs SPRINZ biochemistry lab at AUT Millennium, a hub for many of New Zealands high-performance sports organisations and Olympic …
The Abbott ARCHITECT® ci4100 analyser in AUT’s SPRINZ biochemistry lab, with research operations senior manager Scott Crawford (left), researchers Christi Essex and Maggie Sandleback, and AUT Professor Alice Theadom. (Photo/Supplied)
New Zealand’s leading sports research institute, based at Auckland University of Technology (AUT), has embarked on a multi-year collaboration with global healthcare technology company Abbott. This joint effort has potential to transform how sports injuries are treated in the future, especially for female athletes.
Under the collaboration, Abbott has installed the ARCHITECT® ci4100 analyser, one of its Core Laboratory platforms, in AUT’s SPRINZ biochemistry lab at AUT Millennium, a hub for many of New Zealand’s high-performance sports organisations and Olympic athletes.
Read the full article here
